片仔癀 (600436)

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.

ASH

Tags

300ESG Index300 Non-Cyclical IndexMSCI China A 50 IndexMSCI Component StocksSSE 180 IndexSSE Mid Cap IndexSpecialized-Sophisticated-Distinctive-Innovative EnterprisesChina A80 IndexTraditional Chinese MedicineCSI 100 IndexCSI A100 IndexCSI A50 IndexSpin-off ListingsInnovative DrugsNorthbound Heavy PositionsPharmaceutical ManufacturingPharmaceuticals and HealthcareState-Owned Enterprise ReformGuozheng Growth IndexLarge Cap GrowthLarge Cap StocksSustainable GrowthEmerging Markets IndexCSI 300 IndexWest Coast of the Taiwan StraitHundred-Yuan StocksHigh-Performing StocksHepatitis ConceptMargin Trading and Securities LendingChina Securities Finance and Central Huijin HoldingsTongdaxin 88Galaxy 99 IndexNon-Cyclical Stocks

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 60331.72
  • Circulating A-Shares(W): 60331.72
  • Earnings Per Share(RMB): 3.5300
  • Net Assets Per Share(RMB): 23.9878
  • Operating Revenue(W RMB): 744236.61
  • Total Profit(W RMB): 248506.34
  • **Net Profit Attributable to Parent(W RMB) **: 212934.77
  • Net Profit Growth Rate(%): -20.74
  • Weighted Return on Equity(%): 14.3100
  • Operating Cash Flow Per Share(RMB): 0.8070
  • Undistributed Profit Per Share(RMB): 17.8896
  • Capital Reserve Per Share(RMB): 1.8147

2. Main Business

The main business covers:

  • Production and sales of Pien Tze Huang series and other Chinese patent medicines

3. Company Basic Information

  • Company Name: Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd.
  • Listing Date: 2003-06-16
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 1 Hupo Road, Xiangcheng District, Zhangzhou City, Fujian Province
  • Website: https://www.zzpzh.com/
  • Company Profile: Approved by the Fujian Provincial Government Document Min Zheng Ti Gu [1999] No. 31, Pien Tze Huang Group, as the main sponsor, initiated the establishment of the company in December 1999. At the time of establishment, the total share capital was 100 million shares, with a par value of RMB 1.00 per share. Among them, the Group Company subscribed for 80 million shares (80% of the total shares) with the net value of its pharmaceutical-related operating assets after appraisal (excluding land and trademarks) of RMB 96,000,000.00, at a conversion ratio of 1.20:1. The other four sponsors - the Group Company Labor Union, Zhanglong Industrial, Fujian Medicinal Materials Company, and Fujian Zhangzhou Medicine Purchasing and Supply Station - subscribed for 10 million shares, 6 million shares, 2 million shares, and 2 million shares respectively in cash at RMB 1.20 per share, accounting for 10%, 6%, 2%, and 2% of the total share capital respectively.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Zhangzhou Jiulongjiang Group Co., Ltd. General Legal Person 30752.26 50.97
2 Zhangzhou State-owned Capital Operation Group Co., Ltd. General Legal Person 1933.24 3.20
3 China Securities Finance Co., Ltd. Special Legal Person 1125.35 1.87
4 Hong Kong Securities Clearing Company Ltd. Northbound Funds 1050.24 1.74
5 Fujian Zhanglong Group Co., Ltd. General Legal Person 705.67 1.17
6 Zhangzhou Transportation Development Group Co., Ltd. General Legal Person 630.00 1.04
7 Huatai-Pinebridge SSE 300 Index ETF Fund 508.01 0.84
8 Fujian Zhangzhou Chengtou Group Co., Ltd. General Legal Person 480.00 0.80
9 E Fund SSE 300 Healthcare Sector ETF Fund 377.64 0.63
10 ChinaAMC CSI Traditional Chinese Medicine Index ETF Fund 125.88 0.21

5. Concept Sectors

  • West Coast of the Taiwan Strait
  • Tongdaxin 88
  • Hepatitis Concept
  • Innovative Drugs

Remarks

  • Data update date: 2025-10-30
  • Data source: Public market information